TMBR Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases

$0.30  -0.01 (-3.34%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/04/2015
Outstanding shares:  63,678,836
Average volume:  837,981
Market cap:   $20,026,994
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.63
PB ratio:   1.83
PS ratio:   20.65
Return on equity:   -113.37%
Net income %:   -1,234.21%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy